QA: Edesa Biotech Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001540159_2023_Edesa_Biotech_Inc.pdf

Logs

Graph

Absolute values for 0001540159, Edesa Biotech Inc.

  xvar xval
0 AssetsCurrent 9,091,913
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,694
3 remainder_Assets 2,471,121
4 LiabilitiesCurrent 2,140,777
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 43,662
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 800
11 remainder_Revenues 0
12 remainder_NetIncome -17,548,124
13 remainder_ComprehensiveNetIncome -8,340
  yvar yval
0 Assets 11,575,728
1 Liabilities 2,184,439
2 Expenses 800
3 Revenues 0
4 StockholdersEquity 9,391,289
5 NetIncome -17,548,924
6 ComprehensiveNetIncome -17,553,094
7 BaseVar 15,658,716
8 EconomicCapitalRatio -0.203

Edgar->Model Mapping

Feature Distribution

Change over Time